Flashback Foreword: Bevacizumab and Irinotecan in Recurrent Glioblastoma. Mellinghoff IK. J Clin Oncol 2023;41:4943-4944.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mellinghoff IK. Flashback Foreword: Bevacizumab and Irinotecan in Recurrent Glioblastoma. J Clin Oncol 2023;41:4943-4944.
PMID: 37935102